Corient Private Wealth’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.4M | Buy |
237,931
+798
| +0.3% | +$31.5K | 0.01% | 585 |
|
|
2025
Q1 | $7.15M | Sell |
237,133
-2,030
| -0.8% | -$61.2K | 0.01% | 581 |
|
|
2024
Q4 | $8.36M | Buy |
239,163
+2,087
| +0.9% | +$73K | 0.01% | 556 |
|
|
2024
Q3 | $9.5M | Sell |
237,076
-30,961
| -12% | -$1.24M | 0.01% | 563 |
|
|
2024
Q2 | $12.8M | Buy |
268,037
+746
| +0.3% | +$35.6K | 0.02% | 471 |
|
|
2024
Q1 | $11.6M | Sell |
267,291
-21
| -0% | -$910 | 0.02% | 491 |
|
|
2023
Q4 | $13.5M | Sell |
267,312
-39,678
| -13% | -$2.01M | 0.02% | 463 |
|
|
2023
Q3 | $13.9M | Buy |
306,990
+1,522
| +0.5% | +$69K | 0.03% | 420 |
|
|
2023
Q2 | $12.5M | Buy |
305,468
+182
| +0.1% | +$7.47K | 0.03% | 432 |
|
|
2023
Q1 | $10.9M | Buy |
305,286
+2,609
| +0.9% | +$93.2K | 0.03% | 419 |
|
|
2022
Q4 | $11.4M | Buy |
+302,677
| New | +$11.4M | 0.04% | 348 |
|